Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/effects-of-chronic-oral-treatment-with-aripiprazole-on-the-expression-GjK08JiJFi
References (114)
-
D. Henderson, Xiaoduo Fan, P. Copeland, Bikash Sharma, C. Borba, Ryan Boxill, O. Freudenreich, C. Cather, A. Evins, D. Goff (2009)
Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia PatientsJournal of Clinical Psychopharmacology, 29
-
L. Fitzgerald, A. Deutch, Gregory Gasic, Stephen Heinemann, Eric Nestler (1995)
Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs, 15
-
F. Henn (1995)
The NMDA receptor as a site for psychopathology. Primary or secondary role?Archives of general psychiatry, 52 12
-
K. Zilles, L. Werner, M. Qü, A. Schleicher, G. Gross (1991)
Quantitative auto radiography of 11 different transmitter binding sites in the basal forebrain region of the rat—Evidence of heterogeneity in distribution patternsNeuroscience, 42
-
C. Cosi, A. Waget, K. Rollet, Valentina Tesori, A. Newman-Tancredi (2005)
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: Role of 5-HT1A receptor activationBrain Research, 1043
-
H. Uylings, van Cg (1990)
Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans.Progress in brain research, 85
-
JT Coyle, G Tsai, D Goff (2003)
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophreniaAnn NY Acad Sci, 1003
-
H. Ibrahim, A. Hogg, D. Healy, V. Haroutunian, K. Davis, J. Meador-Woodruff (2000)
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.The American journal of psychiatry, 157 11
-
Mei Han, Xu-Feng Huang, Chao Deng (2009)
Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.The international journal of neuropsychopharmacology, 12 7
-
C. Konradi, S. Heckers (2003)
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Pharmacology & therapeutics, 97 2
-
T. Nagai, R. Murai, K. Matsui, H. Kamei, Y. Noda, H. Furukawa, T. Nabeshima (2008)
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptorsPsychopharmacology, 202
-
Satoshi Yamamura, Keiko Ohoyama, Tatsuya Hamaguchi, Masanori Nakagawa, Dai Suzuki, Takuya Matsumoto, E. Motomura, H. Tanii, T. Shiroyama, M. Okada (2009)
Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortexBritish Journal of Pharmacology, 157
-
H. El-sayeh, C. Morganti (2006)
Aripiprazole for schizophrenia.The Cochrane database of systematic reviews, 2
-
T. Bowles, G. Levin (2003)
Aripiprazole: A New Atypical Antipsychotic DrugAnnals of Pharmacotherapy, 37
-
G. Duncan, K. Inada, J. Farrington, B. Koller, S. Moy (2009)
Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stressBrain Research, 1265
-
D. Goff, J. Coyle (2001)
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.The American journal of psychiatry, 158 9
-
NB Farber (2003)
The NMDA receptor hypofunction model of psychosisAnn NY Acad Sci, 1003
-
R. Corbett, F. Camacho, A. Woods, L. Kerman, R. Fishkin, K. Brooks, R. Dunn (1995)
Antipsychotic agents antagonize non-competitiveN-methyl-d-aspartate antagonist-induced behaviorsPsychopharmacology, 120
-
Nina Segnitz, A. Schmitt, P. Gebicke-Härter, M. Zink (2009)
Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in ratsNeurochemistry International, 55
-
X. López-Gil, F. Artigas, A. Adell (2009)
Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.The international journal of neuropsychopharmacology, 12 4
-
H. Tan, Qiang Chen, S. Sust, J. Buckholtz, J. Meyers, M. Egan, V. Mattay, A. Meyer-Lindenberg, D. Weinberger, J. Callicott (2007)
Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain functionProceedings of the National Academy of Sciences, 104
-
G. Paxinos, Charles Watson (1983)
The Rat Brain in Stereotaxic Coordinates -
J. Ułas, L. Nguyen, C. Cotman (1993)
Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex.Neuroreport, 4 8
-
J. Leite, F. Guimarães, F. Moreira (2008)
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.European journal of pharmacology, 578 2-3
-
H. Homayoun, B. Moghaddam (2007)
NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal NeuronsThe Journal of Neuroscience, 27
-
Xiangdong Deng, H. Shibata, Naoko Takeuchi, Shinako Rachi, M. Sakai, H. Ninomiya, N. Iwata, N. Ozaki, Y. Fukumaki (2007)
Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophreniaAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B
-
M. Wood, C. Scott, Kirsten Clarke, J. Westaway, C. Davies, C. Reavill, Mark Hill, Claire Rourke, M. Newson, Declan Jones, I. Forbes, A. Gribble (2006)
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.European journal of pharmacology, 546 1-3
-
Huaixing Wang, Wen-Jun Gao (2009)
Cell-type Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal CortexNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 34
-
J. Espinosa, J. Espinosa, D. Wheeler, R. Tsien, Liqun Luo, Liqun Luo (2009)
Uncoupling Dendrite Growth and Patterning: Single-Cell Knockout Analysis of NMDA Receptor 2BNeuron, 62
-
N. Farber (2003)
The NMDA Receptor Hypofunction Model of PsychosisAnnals of the New York Academy of Sciences, 1003
-
J. Kane, W. Carson, A. Saha, R. Mcquade, G. Ingenito, D. Zimbroff, Mirza Ali (2002)
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.The Journal of clinical psychiatry, 63 9
-
M. Kalinichev, Claire Rourke, A. Daniels, M. Grizzle, Christy Britt, D. Ignar, Declan Jones (2005)
Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female ratsPsychopharmacology, 182
-
J. Semba, M. Sakai, R. Miyoshi, N. Mataga, F. Fukamauchi, S. Kito (1996)
DIFFERENTIAL EXPRESSION OF c-fos mRNA IN RAT PREFRONTAL CORTEX, STRIATUM, N. ACCUMBENS AND LATERAL SEPTUM AFTER TYPICAL AND ATYPICAL ANTIPSYCHOTICS: AN IN SITU HYBRIDIZATION STUDYNeurochemistry International, 29
-
M. Millan (2005)
N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectivesPsychopharmacology, 179
-
Gang Lei, N. Anastasio, Yu Fu, V. Neugebauer, K. Johnson (2009)
Activation of dopamine D1 receptors blocks phencyclidine‐induced neurotoxicity by enhancing N‐methyl‐D‐aspartate receptor‐mediated synaptic strengthJournal of Neurochemistry, 109
-
D. Goebel, M. Poosch (1999)
NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A.Brain research. Molecular brain research, 69 2
-
A. Carlsson (2006)
The Neurochemical Circuitry of SchizophreniaPharmacopsychiatry, 39
-
Klaas Stephan, K. Friston, C. Frith (2009)
Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoringSchizophrenia Bulletin, 35
-
S. Englisch, A. Weinbrenner, D. Inta, M. Zink (2009)
Aripiprazole for the management of olanzapine-induced weight gain.Pharmacopsychiatry, 42 4
-
C. Eden, A. Hest, F. Haaren, H. Uylings (1994)
Effects of neonatal mediodorsal thalamic lesions on structure and function of the rat prefrontal cortex.Brain research. Developmental brain research, 80 1-2
-
X. López-Gil, F. Artigas, A. Adell (2010)
Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex.Current pharmaceutical design, 16 5
-
G. Gilmour, E. Pioli, S. Dix, Janice Smith, Michael Conway, Wendy Jones, Sally Loomis, Rebecca Mason, S. Shahabi, M. Tricklebank (2009)
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophreniaPsychopharmacology, 205
-
J. Krystal, E. Perry, R. Gueorguieva, A. Belger, S. Madonick, A. Abi-Dargham, T. Cooper, L. Macdougall, W. Abi-Saab, D. D’Souza (2005)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.Archives of general psychiatry, 62 9
-
M. Cheng, Ding-Lieh Liao, C. Hsiung, Chih-Yu Chen, Yu-Chieh Liao, Chia-Hsiang Chen (2008)
Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex.The international journal of neuropsychopharmacology, 11 2
-
A. Seillier, A. Giuffrida (2009)
Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801Behavioural Brain Research, 204
-
L. Kargieman, N. Santana, G. Mengod, P. Celada, F. Artigas (2007)
Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidineProceedings of the National Academy of Sciences, 104
-
H. El-sayeh, C. Morganti, C. Adams (2006)
Aripiprazole for schizophreniaBritish Journal of Psychiatry, 189
-
S. Shim, Michael Hammonds, B. Kee (2007)
Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine siteEuropean Archives of Psychiatry and Clinical Neuroscience, 258
-
Zhu Li, J. Ichikawa, Jin Dai, H. Meltzer (2004)
Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.European journal of pharmacology, 493 1-3
-
A. Schmitt, M. Zink, B. Müller, B. May, A. Herb, A. Jatzko, D. Braus, F. Henn (2003)
Effects of Long-Term Antipsychotic Treatment on NMDA Receptor Binding and Gene Expression of SubunitsNeurochemical Research, 28
-
T. Moran-Gates, C. Grady, Young Park, R. Baldessarini, F. Tarazi (2007)
Effects of risperidone on dopamine receptor subtypes in developing rat brainEuropean Neuropsychopharmacology, 17
-
K. Zilles, Meishu Qü, R. Köhling, E. Speckmann (1999)
Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiographyNeuroscience, 94
-
S. Snigdha, J. Neill (2008)
Improvement of phencyclidine-induced social behaviour deficits in rats: Involvement of 5-HT1A receptorsBehavioural Brain Research, 191
-
L. Slot, M. Kleven, A. Newman-Tancredi (2005)
Effects of novel antipsychotics with mixed D2 antagonist/5-HT1A agonist properties on PCP-induced social interaction deficits in the ratNeuropharmacology, 49
-
T. Jenkins, M. Harte, G. Reynolds (2010)
Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the ratNeuroscience Letters, 471
-
F. Benes (2009)
Neural Circuitry Models of Schizophrenia: Is it Dopamine, GABA, Glutamate, or Something Else?Biological Psychiatry, 65
-
A. Inoue, M. Seto, S. Sugita, I. Hide, T. Hirose, N. Koga, T. Kikuchi, Y. Nakata (1998)
Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.Brain research. Molecular brain research, 55 2
-
P. Gaspar, M. Bustamante, H. Silva, F. Aboitiz (2009)
Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implicationsJournal of Neurochemistry, 111
-
A. MacDonald, M. Chafee (2006)
Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophreniaDevelopment and Psychopathology, 18
-
Bky Bitanihirwe, MP Lim, JF Kelley, T. Kaneko, Tuw Woo (2009)
Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophreniaBMC Psychiatry, 9
-
M. Zink, S. Rapp, P. Gebicke-haerter, F. Henn, J. Thome (2005)
Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampusPsychopharmacology, 181
-
J. Coyle, G. Tsai, D. Goff (2003)
Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of SchizophreniaAnnals of the New York Academy of Sciences, 1003
-
H. Homayoun, B. Moghaddam (2008)
Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugsProceedings of the National Academy of Sciences, 105
-
FA Henn (1995)
The NMDA-receptor as a site for pathogenesisArch Gen Psychiatry, 52
-
S. Snigdha, M. Horiguchi, Mei Huang, Zhu Li, M. Shahid, J. Neill, H. Meltzer (2010)
Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine2A Receptor Inverse AgonistJournal of Pharmacology and Experimental Therapeutics, 332
-
P. Baier, A. Blume, J. Koch, A. Marx, G. Fritzer, J. Aldenhoff, T. Schiffelholz (2009)
Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats—A possible model for schizophreniaBehavioural Brain Research, 205
-
Paul Harrison, D. Weinberger (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMolecular Psychiatry, 10
-
P. Paoletti, J. Neyton (2007)
NMDA receptor subunits: function and pharmacology.Current opinion in pharmacology, 7 1
-
M. Vrajová, F. Št̆astný, J. Horáček, J. Lochman, O. Šerý, S. Pekova, J. Klaschka, C. Höschl (2010)
Expression of the Hippocampal NMDA Receptor GluN1 Subunit and Its Splicing Isoforms in Schizophrenia: Postmortem StudyNeurochemical Research, 35
-
B Moghaddam, ME Jackson (2003)
Glutamatergic animal models of schizophreniaAnn NY Acad Sci, 1003
-
Paul Harrison, A. Law, S. Eastwood (2003)
Glutamate Receptors and Transporters in the Hippocampus in SchizophreniaAnnals of the New York Academy of Sciences, 1003
-
R. Nordquist, C. Risterucci, Jean-Luc Moreau, M. Kienlin, B. Künnecke, M. Maco, C. Freichel, Claus Riemer, Will Spooren (2008)
Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in ratsNeuropharmacology, 54
-
A. Sparshatt, David Taylor, Maxine Patel, S. Kapur (2010)
A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring.The Journal of clinical psychiatry, 71 11
-
JA Lieberman (2004)
Dopamine partial agonists: a new class of antipsychoticCNS Drugs, 18
-
J. Lieberman (2004)
Dopamine Partial AgonistsCNS Drugs, 18
-
A. Schmitt, M. Zink, G. Petroianu, B. May, D. Braus, F. Henn (2003)
Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brainNeuroscience Letters, 347
-
J. Semba, A. Watanabe, S. Kito, Michio Toru (1995)
Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brainNeuropharmacology, 34
-
Tsung-Tsair Yang, Su-Jane Wang (2008)
Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophreniaSynapse, 62
-
A. Roopun, M. Cunningham, C. Racca, K. Alter, R. Traub, M. Whittington (2008)
Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia.Schizophrenia bulletin, 34 5
-
D. Shapiro, Sean Renock, Elaine Arrington, L. Chiodo, Li-xin Liu, D. Sibley, B. Roth, R. Mailman (2003)
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust PharmacologyNeuropsychopharmacology, 28
-
Sandeep Patil, Lu Zhang, F. Martényi, S. Lowe, K. Jackson, B. Andreev, A. Avedisova, L. Bardenstein, I. Gurovich, M. Morozova, S. Mosolov, N. Neznanov, A. Reznik, A. Smulevich, V. Tochilov, Bryan Johnson, J. Monn, D. Schoepp (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 13
-
A. Meyer-Lindenberg, D. Weinberger (2006)
Intermediate phenotypes and genetic mechanisms of psychiatric disordersNature Reviews Neuroscience, 7
-
B. Moghaddam, M. Jackson (2003)
Glutamatergic Animal Models of SchizophreniaAnnals of the New York Academy of Sciences, 1003
-
R. Kern, Michael Green, Barbara Cornblatt, J. Owen, R. Mcquade, William Carson, Mirza Ali, R. Marcus (2006)
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapinePsychopharmacology, 187
-
S. Jordan, V. Koprivica, R. Dunn, K. Tottori, T. Kikuchi, C. Altar (2004)
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.European journal of pharmacology, 483 1
-
C. Eden, J. Kros, H. Uylings (1990)
The development of the rat prefrontal cortex. Its size and development of connections with thalamus, spinal cord and other cortical areas.Progress in brain research, 85
-
PJ Harrison, AJ Law, SL Eastwood (2003)
Glutamate receptors and transporters in the hippocampus in schizophreniaAnn NY Acad Sci, 1003
-
T. Bois, Chao Deng, Mei Han, K. Newell, Xu-Feng Huang (2009)
Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockadeEuropean Neuropsychopharmacology, 19
-
F. Tarazi, Y. Choi, M. Gardner, E. Wong, B. Henry, M. Shahid (2009)
Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brainSynapse, 63
-
K. Wirkner, T. Krause, L. Köles, S. Thümmler, M. Al-Khrasani, P. Illés (2004)
D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortexNeuroscience Letters, 372
-
C. Eden, A. Rinkens, H. Uylings (1998)
Retrograde degeneration of thalamic neurons in the mediodorsal nucleus after neonatal and adult aspiration lesions of the medial prefrontal cortex in the rat. Implications for mechanisms of functional recoveryEuropean Journal of Neuroscience, 10
-
Chunmei Guo, Yang Yang, Yun'ai Su, T. Si (2010)
Postnatal BDNF Expression Profiles in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by MK-801 AdministrationJournal of Biomedicine and Biotechnology, 2010
-
T. Tran-Johnson, D. Sack, R. Marcus, P. Auby, R. Mcquade, D. Oren (2007)
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.The Journal of clinical psychiatry, 68 1
-
Satoshi Yamamura, Keiko Ohoyama, Tatsuya Hamaguchi, Kanae Kashimoto, Masanori Nakagawa, Shin Kanehara, Dai Suzuki, Takuya Matsumoto, E. Motomura, T. Shiroyama, M. Okada (2009)
Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortexPsychopharmacology, 206
-
M. Gielen, Beth Retchless, Laetitia Mony, Jon Johnson, P. Paoletti (2009)
Mechanism of differential control of NMDA receptor activity by NR2 subunitsNature, 459
-
L. Dahan, H. Husum, O. Mnie-Filali, J. Arnt, P. Hertel, N. Haddjeri (2009)
Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviourJournal of Psychopharmacology, 23
-
J. Belforte, V. Zsiros, Elyse Sklar, Zhihong Jiang, G.-Z. Yu, Yuqing Li, E. Quinlan, K. Nakazawa (2010)
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypesNature Neuroscience, 13
-
A Inoue, M Seto, S Sugita, I Hide, T Hirose, N Koga, T Kikuchi, Y Nakata (1998)
Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitaryMol Brain Res, 2
-
S. McLean, N. Idris, M. Woolley, J. Neill (2009)
D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophreniaEuropean Neuropsychopharmacology, 19
-
E. Rolls, Marco Loh, G. Deco, G. Winterer (2008)
Computational models of schizophrenia and dopamine modulation in the prefrontal cortexNature Reviews Neuroscience, 9
-
Ming Li, R. Budin, A. Fleming, S. Kapur (2005)
Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in ratsPsychopharmacology, 181
-
S. Potvin, E. Stip, J. Roy (2005)
Toxic Psychoses as Pharmacological Models of SchizophreniaCurrent Psychiatry Reviews, 1
-
G. González-Burgos, D. Lewis (2008)
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.Schizophrenia bulletin, 34 5
-
S. Bickel, D. Javitt (2009)
Neurophysiological and neurochemical animal models of schizophrenia: Focus on glutamateBehavioural Brain Research, 204
-
T. Walsh, J. McClellan, S. McCarthy, A. Addington, S. Pierce, G. Cooper, A. Nord, M. Kusenda, D. Malhotra, A. Bhandari, S. Stray, C. Rippey, P. Roccanova, Vladimir Makarov, B. Lakshmi, R. Findling, L. Sikich, T. Stromberg, B. Merriman, N. Gogtay, P. Butler, K. Eckstrand, L. Noory, P. Gochman, R. Long, Zugen Chen, S. Davis, Carl Baker, E. Eichler, P. Meltzer, S. Nelson, A. Singleton, Ming Lee, J. Rapoport, M. King, J. Sebat (2008)
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in SchizophreniaScience, 320
-
R. Squires, E. Saederup (1991)
A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of “functional” psychosisNeurochemical Research, 16
-
A. Funk, Gavin Rumbaugh, Vahram Harotunian, R. Mccullumsmith, J. Meador-Woodruff (2009)
Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophreniaNeuroReport, 20
-
R. Paz, Sonia Tardito, M. Atzori, Kuei Tseng (2008)
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacologyEuropean Neuropsychopharmacology, 18
-
Rebekah Corlew, D. Brasier, D. Feldman, B. Philpot (2008)
Presynaptic NMDA Receptors: Newly Appreciated Roles in Cortical Synaptic Function and PlasticityThe Neuroscientist, 14
-
K. Fejgin, Sergej Safonov, E. Pålsson, C. Wass, J. Engel, L. Svensson, D. Klamer (2007)
The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in micePsychopharmacology, 191
-
J. Stone, P. Morrison, L. Pilowsky (2007)
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective reviewJournal of Psychopharmacology, 21
-
L. Kristiansen, Ibone Huerta, M. Beneyto, J. Meador-Woodruff (2007)
NMDA receptors and schizophrenia.Current opinion in pharmacology, 7 1
-
A. Bortolozzi, L. Díaz-Mataix, M. Toth, P. Celada, F. Artigas (2007)
In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brainPsychopharmacology, 191
-
J. Gordon (2010)
Testing the glutamate hypothesis of schizophreniaNature Neuroscience, 13
- Publisher
- Springer Journals
- Copyright
- Copyright © 2011 by Springer-Verlag
- Subject
- Biomedicine; Pharmacology/Toxicology; Psychiatry; Neurosciences
- ISSN
- 0033-3158
- eISSN
- 1432-2072
- DOI
- 10.1007/s00213-011-2262-z
- pmid
- 21484241
- Publisher site
- See Article on Publisher Site
Abstract
The effects of APZ converge in enhanced NMDA receptor expression and a shift of subunit composition towards adult-type receptors. Our results confirm the regulatory connections between dopaminergic, serotonergic, and glutamatergic neurotransmissions with relevance for cognitive and negative symptoms of schizophrenia.
Journal
Psychopharmacology – Springer Journals
Published: Sep 1, 2011